Posted inPharma Marketing AI as Patient Advocate: Streamlining Administrative Burdens for Cancer Care Posted by OncoDoc September 5, 2025 A Pharma Marketing Perspective on Prior Authorizations, Scheduling, and Workflow Efficiency Introduction: Redefining Oncology Care…
Posted inPharma Marketing Binge-Worthy Insights: Is Your Pharma Engagement as Compelling as Netflix? What Oncologists Really Want Posted by OncoDoc September 4, 2025 Abstract In an era saturated with information and personalized digital experiences, healthcare professionals (HCPs), particularly…
Posted inPharma Marketing Beyond Remission: Are Pharma and Physicians Ready for the Long-Term Journey of Immunotherapy and Targeted Therapy Survivors? Posted by OncoDoc September 3, 2025 Abstract The advent of immunotherapy (IO) and targeted therapies (TT) has dramatically reshaped the landscape…
Posted inPharma Marketing Onco-Stories: The Rise of AI-Generated, Survivor-Driven Content Posted by OncoDoc September 3, 2025 Introduction: A Paradigm Shift in Oncology Pharma Marketing Oncology marketing is entering a new storytelling…
Posted inPharma Marketing Oncology 2030: The Rise of Predictive, Personalized, and Patient-Centric Pharma Marketing Posted by OncoDoc September 3, 2025 Introduction: The Dawn of a Fully AI-Integrated Oncology Pharma Era By 2030, oncology pharma marketing…
Posted inPharma Marketing Are You Losing Doctors’ Attention? Re-Engage with AI in Oncology Marketing Posted by OncoDoc September 2, 2025 Abstract The oncology landscape in the US is rapidly evolving, marked by scientific breakthroughs, an…
Posted inPharma Marketing From Lab to Launch: Accelerating Oncology Drug Commercialization with AI-Driven Insights Posted by OncoDoc September 2, 2025 Introduction: The AI-Powered Future of Oncology Commercialization The journey of an oncology drug from discovery…
Posted inPharma Marketing The New Era of Precision Engagement: AI’s Transformative Role in Oncology Pharma Marketing in 2025 Posted by OncoDoc September 2, 2025 Introduction: Precision Marketing at a Tipping Point Oncology pharma marketing has entered a defining moment…
Posted inPharma Marketing Why 70% of Oncology Drug Launches Falter? How AI-Powered Digital Marketing Platforms, like Hidoc, are Rewriting the Rules for US Pharma Posted by OncoDoc September 1, 2025 Abstract The oncology drug development landscape is notoriously challenging, with a staggering 70% of new…
Posted inPharma Marketing Beyond the Scroll: Can Unnati Drive Unprecedented Oncology Awareness for US Pharma? Posted by OncoDoc August 30, 2025 Abstract In the complex and rapidly evolving US oncology market, driving effective awareness among Healthcare…